22.01.2015 Views

1opj6id

1opj6id

1opj6id

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MANUAL DE PROTOCOLOS Y ACTUACIÓN EN URGENCIAS<br />

BIBLIOGRAFÍA<br />

Body JJ. Hypercalcemia of malignancy. Semin Nephrol. 2004;24:48.<br />

Cairo MS, Coiffier B, Reiter A, et al. Recommendations for the evaluation of risk and prophylaxis of tumour<br />

lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br<br />

J Haematol. 2010;149:578.<br />

Coleman RE, McCloskey EV. Bisphosphonates in oncology. Bone. 2011. pp. 49:71.<br />

De Naurois J, Novitzky-Basso I, Gill MJ, et al. Management of febrile neutropenia: ESMO Clinical Practice<br />

Guidelines. Ann Oncol. 2010;21(Suppl 5):v252.<br />

Hummel M, Reiter S, Adam K, et al. Effective treatment and prophylaxis of hyperuricemia and impaired<br />

renal function in tumor lysis syndrome with low doses of rasburicase. Eur J Haematol. 2008; 80:331.<br />

Jeha S, Kantarjian H, Irwin D, et al. Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek),<br />

in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results<br />

of a multicenter compassionate use trial. Leukemia. 2005;19:34.<br />

National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Prevention and<br />

treatment of cancer-related infections. Version 1.2012. http://www.nccn.org (Accessed on January 03,<br />

2013).<br />

Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005. pp. 352:373.<br />

862 l Capítulo 92

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!